Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Sorrento Therpt (SRNE)

Sorrento Therpt (SRNE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,139,564
  • Shares Outstanding, K 285,656
  • Annual Sales, $ 39,990 K
  • Annual Income, $ -298,460 K
  • 60-Month Beta 2.40
  • Price/Sales 53.15
  • Price/Cash Flow N/A
  • Price/Book 13.80
Trade SRNE with:

Options Overview

Details
  • Implied Volatility 94.68%
  • Historical Volatility 64.91%
  • IV Percentile 1%
  • IV Rank 4.04%
  • IV High 318.27% on 05/15/20
  • IV Low 85.26% on 03/24/21
  • Put/Call Vol Ratio 0.21
  • Today's Volume 14,741
  • Volume Avg (30-Day) 14,874
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 343,114
  • Open Int (30-Day) 272,523

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.18
  • Number of Estimates 4
  • High Estimate 1.38
  • Low Estimate -0.34
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +169.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.78 +10.47%
on 04/13/21
10.16 -26.28%
on 03/18/21
-2.69 (-26.42%)
since 03/16/21
3-Month
6.78 +10.47%
on 04/13/21
17.25 -56.58%
on 02/08/21
-2.01 (-21.16%)
since 01/15/21
52-Week
2.18 +243.58%
on 05/01/20
19.39 -61.37%
on 08/10/20
+4.74 (+172.86%)
since 04/16/20

Most Recent Stories

More News
New Strong Sell Stocks for March 31st

AROW, BGS, KEX, SRNE, and TOSYY have been added to the Zacks Rank #5 (Strong Sell) List on March 31, 2021

KEX : 62.17 (+0.94%)
TOSYY : 20.5500 (-5.52%)
BGS : 30.07 (+0.60%)
AROW : 34.00 (-0.18%)
SRNE : 7.49 (+0.67%)
A US Government Interagency Group Defines Three Classes Of SARS-Cov-2 Variants

, /PRNewswire/ -- While the world has reason to become optimistic about seeing a light at the end of the tunnel, due to the development of vaccines to fight and rein in the current global pandemic, more...

AZN : 50.74 (-0.18%)
BIOV.CN : 0.360 (-5.26%)
LMNGF : 0.2963 (-1.23%)
SRNE : 7.49 (+0.67%)
NVAX : 227.35 (+12.50%)
MRNA : 170.81 (+6.84%)
Thinking about trading options or stock in Netflix, Novavax, Sorrento Therapeutics, Pfizer, or Johnson & Johnson?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NFLX, NVAX, SRNE, PFE, and JNJ.

NFLX : 546.54 (-0.49%)
NVAX : 227.35 (+12.50%)
SRNE : 7.49 (+0.67%)
JNJ : 162.24 (+1.15%)
PFE : 38.57 (+2.58%)
Diagnostic Improvements Play a Key Role in the Abatement of the Pandemic

, /PRNewswire/ -- Since the pandemic's inception and the subsequent pressure the healthcare infrastructure faced, effective mass testing has been necessary to come up with a proper plan to reduce case...

TOMDF : 0.0480 (-3.03%)
SRNE : 7.49 (+0.67%)
VXRT : 5.35 (-1.38%)
ABT : 124.35 (+0.33%)
OPK : 4.34 (+0.46%)
Lee's Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Clearance to Start Phase 3 Trial as a First-line Treatment of Extensive-stage Small-Cell Lung Cancer

China Oncology Focus Limited (COF), an affiliate of Lee's Pharmaceutical Holdings Limited (Lee's Pharm, HKEX: 950) announced that its anti-PD-L1 antibody, Socazolimab, licensed from Sorrento to COF for...

SRNE : 7.49 (+0.67%)
Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the following upcoming conference:

SRNE : 7.49 (+0.67%)
Sorrento Therapeutics (SRNE) Stock Sinks As Market Gains: What You Should Know

Sorrento Therapeutics (SRNE) closed at $10.97 in the latest trading session, marking a -0.32% move from the prior day.

SRNE : 7.49 (+0.67%)
Sorrento Therape Has Returned 47.5% Since SmarTrend Recommendation (SRNE)

SmarTrend identified an Uptrend for Sorrento Therape (NASDAQ:SRNE) on November 19th, 2020 at $7.41. In approximately 3 months, Sorrento Therape has returned 47.47% as of today's recent price of $10.92....

SRNE : 7.49 (+0.67%)
Sorrento Therapeutics (SRNE) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Sorrento Therapeutics (SRNE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SRNE : 7.49 (+0.67%)
Thinking about buying stock in GameStop, Verb Technology, Brickell Biotech, Creative Realities, or Sorrento Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GME, VERB, BBI, CREX, and SRNE.

CREX : 1.2100 (-10.37%)
BBI : 0.8441 (+0.49%)
VERB : 1.1300 (unch)
SRNE : 7.49 (+0.67%)
GME : 154.69 (-1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

3rd Resistance Point 8.22
2nd Resistance Point 7.93
1st Resistance Point 7.71
Last Price 7.49
1st Support Level 7.20
2nd Support Level 6.91
3rd Support Level 6.69

See More

52-Week High 19.39
Fibonacci 61.8% 12.82
Fibonacci 50% 10.78
Fibonacci 38.2% 8.75
Last Price 7.49
52-Week Low 2.18

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar